Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 4365715, 10 pages
https://doi.org/10.1155/2017/4365715
Research Article

Phylogenetic Tree Analysis of the Cold-Hot Nature of Traditional Chinese Marine Medicine for Possible Anticancer Activity

1School of Information Management, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
2Department of Neurology, Qingdao Municipal Hospital, Qingdao 266011, China
3Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, Malaysia
4Key Laboratory of Marine Drugs, Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong Province 266003, China

Correspondence should be addressed to Xianjun Fu; moc.liamtoh@uixnaix and Zhenguo Wang; moc.621@wougnehz

Received 30 August 2016; Revised 30 October 2016; Accepted 4 December 2016; Published 12 January 2017

Academic Editor: Thierry Hennebelle

Copyright © 2017 Xianjun Fu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X.-J. Fu, Z.-G. Wang, Y. Qu, P. Wang, Y. Zhou, and H.-Y. Yu, “Study on the networks of ‘nature-family-component’ of Chinese medicinal herbs based on association rules mining,” Chinese Journal of Integrative Medicine, vol. 19, no. 9, pp. 663–667, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Liang, L. Li, M. Wang et al., “Molecular network and chemical fragment-based characteristics of medicinal herbs with cold and hot properties from Chinese medicine,” Journal of Ethnopharmacology, vol. 148, no. 3, pp. 770–779, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Zhou, J. Wang, X. Zhang et al., “Investigation of the differences between the ‘COLD’ and ‘HOT’ nature of Coptis chinensis Franch and its processed materials based on animal's temperature tropism,” Science in China Series C: Life Sciences, vol. 52, no. 11, pp. 1073–1080, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. P. Li, “Toward an integrative framework of indigenous research: the geocentric implications of Yin-Yang Balance,” Asia Pacific Journal of Management, vol. 29, no. 4, pp. 849–872, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Ma, C. Tan, H. Zhang, M. Wang, W. Ding, and S. Li, “Bridging the gap between traditional Chinese medicine and systems biology: the connection of cold syndrome and NEI network,” Molecular BioSystems, vol. 6, no. 4, pp. 613–619, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Mohd Fauzi, A. Koutsoukas, R. Lowe et al., “Chemogenomics approaches to rationalizing the mode-of-action of traditional chinese and ayurvedic medicines,” Journal of Chemical Information and Modeling, vol. 53, no. 3, pp. 661–673, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. L.-P. Huang, M. F. Zhu, R. Y. Yu, J. Q. Du, and H. N. Liu, “Study on discrimination mode of cold and hot properties of traditional chinese medicines based on biological effects,” Zhongguo Zhongyao Zazhi, vol. 39, no. 17, pp. 3353–3358, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Zhao, Y. Zhao, J. Wang et al., “Expression of the difference between the Cold (Han) and Hot (Re) natures of traditional Chinese medicines (Strobal and Rhubarb) based on the cold/hot plate differentiating assay,” Science in China, Series C: Life Sciences, vol. 52, no. 12, pp. 1192–1197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Fu, H. Guan, W. Qiangming et al., “Elementary exploration of the orion and development of marine Chlnelle materla medica,” Chinese Journal of Medical History, vol. 39, no. 3, pp. 168–172, 2009. View at Google Scholar
  10. X. Fu, M. Zhang, C. Shao et al., “Chinese marine materia medica resources: status and potential,” Marine Drugs, vol. 14, no. 3, p. 46, 2016. View at Publisher · View at Google Scholar
  11. M. Terasaki, A. Hirose, B. Narayan et al., “Evaluation of recoverable functional lipid components of several brown seaweeds (phaeophyta) from japan with special reference to fucoxanthin and fucosterol contents,” Journal of Phycology, vol. 45, no. 4, pp. 974–980, 2009. View at Publisher · View at Google Scholar
  12. S.-E. N. Ayyad, S. T. Ezmirly, S. A. Basaif, W. M. Alarif, A. F. Badria, and F. A. Badria, “Antioxidant, cytotoxic, antitumor, and protective DNA damage metabolites from the red sea brown alga Sargassum sp,” Pharmacognosy Research, vol. 3, no. 3, pp. 160–165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. H.-F. Tang, Y.-H. Yi, X.-S. Yao, Q.-Z. Xu, S.-Y. Zhang, and H.-W. Lin, “Bioactive steroids from the brown alga Sargassum carpophyllum,” Journal of Asian Natural Products Research, vol. 4, no. 2, pp. 95–101, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. M. Ham, K. N. Kim, W. J. Lee, N. H. Lee, and C. G. Hyun, “Chemical constituents from Sargassum micracanthum and antioxidant activity,” International Journal of Pharmacology, vol. 6, no. 2, pp. 147–151, 2010. View at Google Scholar
  15. M. Khanavi, R. Gheidarloo, N. Sadati et al., “Cytotoxicity of fucosterol containing fraction of marine algae against breast and colon carcinoma cell line,” Pharmacognosy Magazine, vol. 8, no. 29, pp. 60–64, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kobayashi, A. Hasegawa, and H. Mitsuhashi, “Marine sterols. XV. Isolation of 24-vinyloxycholesta-5,23-dien-3β-ol from the brown alga Sargassum thumbergii,” Chemical and Pharmaceutical Bulletin, vol. 33, no. 9, pp. 4012–4013, 1985. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Yang, J. Li, Y. Zheng et al., “Drug activity screening based on microsomes-hydrogel system in predicting metabolism induced antitumor effect of oroxylin A,” Scientific Reports, vol. 6, article no. 21604, 2016. View at Publisher · View at Google Scholar
  18. M. Sugumaran and W. E. Robinson, “Bioactive dehydrotyrosyl and dehydrodopyl compounds of marine origin,” Marine Drugs, vol. 8, no. 12, pp. 2906–2935, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Fu, Z. Wang, C. Wang et al., “The distribution and association relationships of marine Chinese medicine with different nature in the phylogenetic tree of marine organisms,” Modernization of Traditional Chinese Medicine and Materia Medica. World Science and Technology, vol. 17, no. 11, pp. 2189–2196, 2015 (Chinese). View at Publisher · View at Google Scholar
  20. X. Fu, C. Pan, S. Lin et al., “Study on nature distribution of marine Chinese medicine based on literature mining,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 31, no. 1, pp. 96–100, 2016. View at Google Scholar
  21. P. A. Harnedy and R. J. FitzGerald, “Bioactive peptides from marine processing waste and shellfish: a review,” Journal of Functional Foods, vol. 4, no. 1, pp. 6–24, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. S. G. Guan and H. S. Wang, Chinese Marine Materia Medica, Shanghai Scientific and Technical Publishers, Shanghai, China, 2009.
  23. S. Singh, A. E. Carpenter, and A. Genovesio, “Increasing the content of high-content screening: an overview,” Journal of Biomolecular Screening, vol. 19, no. 5, pp. 640–650, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Zhu, C. Qin, L. Tao et al., “Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 31, pp. 12943–12948, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Mcbride and S. K. Butler, “Eribulin mesylate: a novel halichondrin B analogue for the treatment of metastatic breast cancer,” American Journal of Health-System Pharmacy, vol. 69, no. 9, pp. 745–755, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Zhu, X. H. Ma, C. Qin et al., “Drug discovery prospect from untapped species: indications from approved natural product drugs,” PLoS ONE, vol. 7, no. 7, Article ID e39782, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Pean, S. Klaar, E. G. Berglund et al., “The European Medicines Agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human use,” Clinical Cancer Research, vol. 18, no. 17, pp. 4491–4497, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. D. L. Wheeler, T. Barrett, D. A. Benson et al., “Database resources of the national center for biotechnology information,” Nucleic Acids Research, vol. 35, supplement 1, pp. D5–D12, 2007. View at Publisher · View at Google Scholar
  29. F. D. Ciccarelli, T. Doerks, C. Von Mering, C. J. Creevey, B. Snel, and P. Bork, “Toward automatic reconstruction of a highly resolved tree of life,” Science, vol. 311, no. 5765, pp. 1283–1287, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Zhang, S. Gao, M. J. Lercher, S. Hu, and W.-H. Chen, “EvolView, an online tool for visualizing, annotating and managing phylogenetic trees,” Nucleic Acids Research, vol. 40, no. 1, pp. W569–W572, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Letunic and P. Bork, “Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation,” Bioinformatics, vol. 23, no. 1, pp. 127–128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Hahsler, B. Grun, and K. Hornik, “The arules package: mining association rules and frequent itemsets, version 0.6-6,” 2008.
  33. J. Fürnkranz, Association Rule, Encyclopedia of Systems Biology, Springer, New York, NY, USA, 2013.
  34. E. Dasseni, V. S. Verykios, A. K. Elmagarmid, and E. Bertino, “Hiding association rules by using confidence and support,” in Information Hiding, vol. 2137 of Lecture Notes in Computer Science, pp. 369–383, Springer, Berlin, Germany, 2001. View at Publisher · View at Google Scholar
  35. F. Lazcano-Pérez, S. A. Román-González, N. Sánchez-Puig, and R. Arreguín-Espinosa, “Bioactive peptides from marine organisms: a short overview,” Protein and Peptide Letters, vol. 19, no. 7, pp. 700–707, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Faircloth and M. del Carmen Cuevas Marchante, “Kahalalide F and ES285: potent anticancer agents from marine molluscs,” in Molluscs: From Chemo-Ecological Study to Biotechnological Application, vol. 43 of Progress in Molecular and Subcellular Biology, pp. 363–379, Springer, Berlin, Germany, 2006. View at Publisher · View at Google Scholar
  37. B. Pejin, M. Mojovic, and A. G. Savic, “Novel and highly potent antitumour natural products from cnidarians of marine origin,” Natural Product Research, vol. 28, no. 24, pp. 2237–2244, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. N. G. M. Gomes, F. Lefranc, A. Kijjoa, and R. Kiss, “Can some marine-derived fungal metabolites become actual anticancer agents?” Marine Drugs, vol. 13, no. 6, pp. 3950–3991, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. L. A. Salvador-Reyes, N. Engene, V. J. Paul, and H. Luesch, “Targeted natural products discovery from marine cyanobacteria using combined phylogenetic and mass spectrometric evaluation,” Journal of Natural Products, vol. 78, no. 3, pp. 486–492, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Leliaert, A. Tronholm, C. Lemieux et al., “Chloroplast phylogenomic analyses reveal the deepest-branching lineage of the Chlorophyta, Palmophyllophyceae class. nov.,” Scientific Reports, vol. 6, Article ID 25367, 2016. View at Publisher · View at Google Scholar
  41. X. Kai and M. Mingsan, “The characteristics and the modern research of potency cold,” Chinese Journal of Chinese Medicine, vol. 28, no. 182, pp. 1006–1008, 2013. View at Google Scholar
  42. T. L. Simmons, E. Andrianasolo, K. McPhail, P. Flatt, and W. H. Gerwick, “Marine natural products as anticancer drugs,” Molecular Cancer Therapeutics, vol. 4, no. 2, pp. 333–342, 2005. View at Google Scholar · View at Scopus
  43. E. A. Gontang, S. P. Gaudêncio, W. Fenical, and P. R. Jensen, “Sequence-based analysis of secondary-metabolite biosynthesis in marine actinobacteria,” Applied and Environmental Microbiology, vol. 76, no. 8, pp. 2487–2499, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Wink and G. I. A. Mohamed, “Evolution of chemical defense traits in the Leguminosae: mapping of distribution patterns of secondary metabolites on a molecular phylogeny inferred from nucleotide sequences of the rbcL gene,” Biochemical Systematics and Ecology, vol. 31, no. 8, pp. 897–917, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. C. W. Levy, A. Roujeinikova, S. Sedelnikova et al., “Molecular basis of triclosan activity,” Nature, vol. 398, no. 6726, pp. 383–384, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. D.-X. Kong, Y.-Y. Jiang, and H.-Y. Zhang, “Marine natural products as sources of novel scaffolds: achievement and concern,” Drug Discovery Today, vol. 15, no. 21-22, pp. 884–886, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. V. J. Paul and W. Fenical, “Natural products chemistry and chemical defense in tropical marine algae of the phylum Chlorophyta,” in Bioorganic Marine Chemistry, vol. 1 of Bioorganic Marine Chemistry, pp. 1–29, Springer, Berlin, Germany, 1987. View at Publisher · View at Google Scholar
  48. Y. Pengzhan, Z. Quanbin, L. Ning, X. Zuhong, W. Yanmei, and L. Zhi'en, “Polysaccharides from Ulva pertusa (Chlorophyta) and preliminary studies on their antihyperlipidemia activity,” Journal of Applied Phycology, vol. 15, no. 1, pp. 21–27, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Noda, H. Amano, K. Arashima, and K. Nisizawa, “Antitumor activity of marine algae,” Hydrobiologia, vol. 204-205, no. 1, pp. 577–584, 1990. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Xianjun, W. Peng, and W. Zhenguo, “Hypothesis on building of chemical constituent element system of cold-heat nature based on study of ‘nature-structure relationship’ of traditional Chinese medicine,” Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology, vol. 13, no. 5, pp. 919–924, 2011. View at Google Scholar
  51. C. Xiao, D. Li, and H. Wang, “Medicinal composition of main economic algae in our China,” Northwest Pharmaceutical Journal, vol. 23, no. 6, pp. 408–410, 2008. View at Google Scholar